Israel - English - Ministry of Health

lundbeck israel ltd. - nalmefene as hydrochloride dihydrate - film coated tablets - nalmefene as hydrochloride dihydrate 18.06 mg - nalmefene - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (drl), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drl two weeks after initial assessment.

Israel - English - Ministry of Health

lundbeck israel ltd. - nalmefene as hydrochloride dihydrate - film coated tablets - nalmefene as hydrochloride dihydrate 18.06 mg - nalmefene - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (drl), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drl two weeks after initial assessment.

Israel - English - Ministry of Health

promedico ltd - selinexor - tablets - selinexor 20 mg - selinexor - multiple myeloma• xpovio® in combination with bortezomib and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.• xpovio in combination with dexamethasone is indicated for the treatment of adult patients with relapsed refractory multiple myeloma (rrmm) who have received at least three prior therapies and whose disease is refractory to at least one proteasome inhibitor (pi), at least one immunomodulatory agent (imid), and an anti- cd38 monoclonal antibody (mab).diffuse large b-cell lymphomaxpovio is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl), not otherwise specified, including dlbcl arising from follicular lymphoma, after at least 2 lines of systemic therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - difelikefalin acetate, quantity: 55 microgram (equivalent: difelikefalin, qty 50 microgram) - injection, solution - excipient ingredients: sodium chloride; sodium acetate trihydrate; acetic acid; water for injections - korsuva is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis.

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - nafarelin acetate (unii: 8enz0qjw4h) (nafarelin - unii:1x0094v6jv) - nafarelin 2 mg in 1 ml - (for endometriosis, see reverse side ) synarel is indicated for treatment of central precocious puberty (cpp) (gonadotropin-dependent precocious puberty) in children of both sexes. the diagnosis of central precocious puberty (cpp) is suspected when premature development of secondary sexual characteristics occurs at or before the age of 8 years in girls and 9 years in boys, and is accompanied by significant advancement of bone age and/or a poor adult height prediction. the diagnosis should be confirmed by pubertal gonadal sex steroid levels and a pubertal lh response to stimulation by native gnrh. pelvic ultrasound assessment in girls usually reveals enlarged uterus and ovaries, the latter often with multiple cystic formations. magnetic resonance imaging or ct-scanning of the brain is recommended to detect hypothalamic or pituitary tumors, or anatomical changes associated with increased intracranial pressure. other causes of sexual precocity, such as congenital adrenal hyperplasia, testotoxicosis, testicular

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

fuji pharmaceutical co.,ltd. - nafarelin acetate hydrate - limpid and colorless nasal solution

Ireland - English - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - insulin human - suspension for injection - 100 iu/ml - insulin (human)

Ireland - English - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - insulin human - solution for injection - 100 iu/ml - insulins and analogues for injection, fast-acting

Australia - English - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - abciximab -

Ireland - English - HPRA (Health Products Regulatory Authority)

eli lilly and company limited - insulin human - solution for injection - 100 iu/ml - insulins and analogues for injection, fast-acting